Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review
Authors:
- Mary Ellen VajraveluMVMary Ellen Vajravelu
- Jared TobolskiJTJared Tobolski
- Evanette BurrowsEBEvanette Burrows
- Marianne ChiluttiMCMarianne Chilutti
- Rui XiaoRXRui Xiao
- Vaneeta BambaVBVaneeta Bamba
- Steven WilliSWSteven Willi
- Andrew PalladinoAPAndrew Palladino
- Jon M. BurnhamJBJon M. Burnham
- Shana E. McCormackSMShana E. McCormack
Open Access
- 22 October 2015
- journal article
- research article
- Published by Springer Nature in International Journal of Pediatric Endocrinology
- Vol. 2015 (1) , 22
Abstract
Corticotropin-Releasing Hormone (CRH) testing is used to evaluate suspected adrenocorticotropic hormone (ACTH) deficiency, but the clinical characteristics that affect response in young children are incompletely understood. Our objective was to determine the effect of age and body size on cortisol response to CRH in children at risk for ACTH deficiency referred for clinical testing. Retrospective, observational study of 297 children, ages 30 days – 18 years, undergoing initial, clinically indicated outpatient CRH stimulation testing at a tertiary referral center. All subjects received 1mcg/kg corticorelin per institutional protocol. Serial, timed ACTH and cortisol measurements were obtained. Patient demographic and clinical factors were abstracted from the medical record. Patients without full recorded anthropometric data, pubertal assessment, ACTH measurements, or clear indication for testing were excluded (number remaining = 222). Outcomes of interest were maximum cortisol after stimulation (peak) and cortisol rise from baseline (delta). Bivariable and multivariable linear regression analyses were used to assess the effects of age and size (weight, height, body mass index (BMI), body surface area (BSA), BMI z-score, and height z-score) on cortisol response while accounting for clinical covariates including sex, race/ethnicity, pubertal status, indication for testing, and time of testing. Subjects were 27 % female, with mean age of 8.9 years (SD 4.5); 75 % were pre-pubertal. Mean peak cortisol was 609.2 nmol/L (SD 213.0); mean delta cortisol was 404.2 nmol/L (SD 200.2). In separate multivariable models, weight, height, BSA and height z-score each remained independently negatively associated (p < 0.05) with peak and delta cortisol, controlling for indication of testing, baseline cortisol, and peak or delta ACTH, respectively. Age was negatively associated with peak but not delta cortisol in multivariable analysis. Despite the use of a weight-based dosing protocol, both peak and delta cortisol response to CRH are negatively associated with several measures of body size in children referred for clinical testing, raising the question of whether alternate CRH dosing strategies or age- or size-based thresholds for adequate cortisol response should be considered in pediatric patients, or, alternatively, whether this finding reflects practice patterns followed when referring children for clinical testing. The online version of this article (doi:10.1186/s13633-015-0018-y) contains supplementary material, which is available to authorized users.Keywords
This publication has 31 references indexed in Scilit:
- Marked Biological Variance in Endocrine and Biochemical Markers in Childhood: Establishment of Pediatric Reference Intervals Using Healthy Community Children from the CALIPER CohortClinical Chemistry, 2013
- Effect of Inhaled Glucocorticoids in Childhood on Adult HeightNew England Journal of Medicine, 2012
- Evaluation of adrenal function using the human corticotrophin‐releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiencyClinical Endocrinology, 2007
- The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing HormoneNew England Journal of Medicine, 1992
- Hazards of pharmacological tests of growth hormone secretion in childhood.BMJ, 1992
- Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.BMJ, 1991
- Pharmacological Testing of Growth Hormone SecretionHormone Research, 1990
- The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemiaEuropean Journal of Endocrinology, 1989
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987
- Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.Journal of Clinical Investigation, 1983